Turning Point Therapeutics Inc
TPTX
Market Cap$0
Close$
$85.97
13.9% upside
Current Fair Value
13.9% upsideUndervalued by 13.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-285,210,000.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-5.79 |
| Beta | -0.19 |
| Outstanding Shares | 49,702,860 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -13.03 |
|---|---|
| PEG | -10.98 |
| Price to Sales | - |
| Price to Book Ratio | 5.03 |
| Enterprise Value to Revenue | -276.04 |
| Enterprise Value to EBIT | 0.83 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.02 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data